Greenberg Traurig Advises OPKO Health on $722M+ Agreement to Sell Select BioReference Health Assets to Labcorp
MIAMI, Oct. 21, 2026 /PRNewswire/ -- Global law firm Greenberg Traurig, P.A. advised OPKO Health, Inc., a multinational biopharmaceutical company, on its agreement to sell select assets of its wholly owned subsidiary, BioReference Health, LLC, to Labcorp. The purchase price for the...
Covered in this story
What has happened since
- Opko Health Inc is up 1.9% since this was published.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $LH yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Labcorp →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.